• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过经过实验验证的计算对接,快速对人抗体-抗原复合物进行结构解析。

Rapid structural characterization of human antibody-antigen complexes through experimentally validated computational docking.

机构信息

Institute for Research in Biomedicine, Via Vela 6, 6500 Bellinzona, Switzerland.

出版信息

J Mol Biol. 2010 Mar 12;396(5):1491-507. doi: 10.1016/j.jmb.2009.12.053. Epub 2010 Jan 4.

DOI:10.1016/j.jmb.2009.12.053
PMID:20053355
Abstract

If we understand the structural rules governing antibody (Ab)-antigen (Ag) interactions in a given virus, then we have the molecular basis to attempt to design and synthesize new epitopes to be used as vaccines or optimize the antibodies themselves for passive immunization. Comparing the binding of several different antibodies to related Ags should also further our understanding of general principles of recognition. To obtain and compare the three-dimensional structure of a large number of different complexes, however, we need a faster method than traditional experimental techniques. While biocomputational docking is fast, its results might not be accurate. Combining experimental validation with computational prediction may be a solution. As a proof of concept, here we isolated a monoclonal Ab from the blood of a human donor recovered from dengue virus infection, characterized its immunological properties, and identified its epitope on domain III of dengue virus E protein through simple and rapid NMR chemical shift mapping experiments. We then obtained the three-dimensional structure of the Ab/Ag complex by computational docking, using the NMR data to drive and validate the results. In an attempt to represent the multiple conformations available to flexible Ab loops, we docked several different starting models and present the result as an ensemble of models equally agreeing with the experimental data. The Ab was shown to bind a region accessible only in part on the viral surface, explaining why it cannot effectively neutralize the virus.

摘要

如果我们了解给定病毒中抗体(Ab)-抗原(Ag)相互作用的结构规则,那么我们就有了分子基础,可以尝试设计和合成新的表位,用作疫苗,或者优化自身抗体用于被动免疫。比较几种不同抗体与相关 Ag 的结合情况,也应该进一步加深我们对识别一般原理的理解。然而,为了获得和比较大量不同复合物的三维结构,我们需要一种比传统实验技术更快的方法。虽然生物计算对接速度很快,但结果可能不够准确。将实验验证与计算预测相结合可能是一种解决方案。作为概念验证,我们从从登革热病毒感染中恢复的人类供体血液中分离出一种单克隆抗体,对其免疫学特性进行了表征,并通过简单快速的 NMR 化学位移映射实验鉴定了其在登革病毒 E 蛋白结构域 III 上的表位。然后,我们通过计算对接获得了 Ab/Ag 复合物的三维结构,利用 NMR 数据来驱动和验证结果。为了表示柔性 Ab 环的多种构象,我们对接了几个不同的起始模型,并将结果表示为与实验数据一致的模型集合。该抗体被证明能结合病毒表面部分暴露的区域,这解释了为什么它不能有效地中和病毒。

相似文献

1
Rapid structural characterization of human antibody-antigen complexes through experimentally validated computational docking.通过经过实验验证的计算对接,快速对人抗体-抗原复合物进行结构解析。
J Mol Biol. 2010 Mar 12;396(5):1491-507. doi: 10.1016/j.jmb.2009.12.053. Epub 2010 Jan 4.
2
Characterization of a dengue type-specific epitope on dengue 3 virus envelope protein domain III.登革 3 型病毒包膜蛋白结构域 III 上的登革热特异性表位的鉴定。
J Gen Virol. 2010 Sep;91(Pt 9):2249-53. doi: 10.1099/vir.0.021220-0. Epub 2010 May 5.
3
Combinatorial Resurfacing of Dengue Envelope Protein Domain III Antigens Selectively Ablates Epitopes Associated with Serotype-Specific or Infection-Enhancing Antibody Responses.组合表面重塑登革热包膜蛋白结构域 III 抗原选择性消除与血清型特异性或感染增强抗体反应相关的表位。
ACS Comb Sci. 2020 Sep 14;22(9):446-456. doi: 10.1021/acscombsci.0c00073. Epub 2020 Jul 20.
4
Structural and Functional Characterization of a Cross-Reactive Dengue Virus Neutralizing Antibody that Recognizes a Cryptic Epitope.一种交叉反应性登革病毒中和抗体的结构与功能特征,该抗体识别隐蔽表位。
Structure. 2018 Jan 2;26(1):51-59.e4. doi: 10.1016/j.str.2017.11.017. Epub 2017 Dec 14.
5
Solution structure of the envelope protein domain III of dengue-4 virus.登革热4型病毒包膜蛋白结构域III的溶液结构
Virology. 2007 Jul 20;364(1):147-54. doi: 10.1016/j.virol.2007.02.023. Epub 2007 Mar 29.
6
Dengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibody.人免疫血清对登革病毒的中和作用:包膜蛋白结构域III反应性抗体的作用
Virology. 2009 Sep 15;392(1):103-13. doi: 10.1016/j.virol.2009.06.037. Epub 2009 Jul 24.
7
Structural analysis of a dengue cross-reactive antibody complexed with envelope domain III reveals the molecular basis of cross-reactivity.结构分析一个登革热交叉反应抗体与包膜域 III 复合物揭示了交叉反应的分子基础。
J Immunol. 2012 May 15;188(10):4971-9. doi: 10.4049/jimmunol.1200227. Epub 2012 Apr 9.
8
Solution structure and neutralizing antibody binding studies of domain III of the dengue-2 virus envelope protein.登革2型病毒包膜蛋白结构域III的溶液结构及中和抗体结合研究
Proteins. 2008 Feb 15;70(3):1116-9. doi: 10.1002/prot.21806.
9
Genotype-specific neutralization and protection by antibodies against dengue virus type 3.针对 3 型登革热病毒的基因型特异性中和与保护作用由抗体介导。
J Virol. 2010 Oct;84(20):10630-43. doi: 10.1128/JVI.01190-10. Epub 2010 Aug 11.
10
Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions.鉴定与人结合的登革病毒粒子上复杂表位的中和抗体。
Proc Natl Acad Sci U S A. 2012 May 8;109(19):7439-44. doi: 10.1073/pnas.1200566109. Epub 2012 Apr 12.

引用本文的文献

1
Mapping Antibody Epitopes by Solution NMR Spectroscopy: Practical Considerations.通过溶液核磁共振光谱法绘制抗体表位:实际考量
Methods Mol Biol. 2025;2937:33-59. doi: 10.1007/978-1-0716-4591-8_3.
2
Discovery of a pan anti-SARS-CoV-2 monoclonal antibody with highly efficient infected cell killing capacity for novel immunotherapeutic approaches.发现一种具有高效感染细胞杀伤能力的泛抗SARS-CoV-2单克隆抗体用于新型免疫治疗方法。
Emerg Microbes Infect. 2025 Dec;14(1):2432345. doi: 10.1080/22221751.2024.2432345. Epub 2024 Dec 9.
3
Human antibodies in Mexico and Brazil neutralizing tick-borne flaviviruses.
墨西哥和巴西的人体抗体中和蜱传黄病毒。
Cell Rep. 2024 Jun 25;43(6):114298. doi: 10.1016/j.celrep.2024.114298. Epub 2024 May 29.
4
19n01, a broadly neutralizing antibody against omicron BA.1, BA.2, BA.4/5, and other SARS-CoV-2 variants of concern.19n01,一种针对奥密克戎BA.1、BA.2、BA.4/5以及其他值得关注的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体的广泛中和抗体。
iScience. 2023 Apr 21;26(4):106562. doi: 10.1016/j.isci.2023.106562. Epub 2023 Apr 1.
5
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface.SARS-CoV-2 中和性人源重组抗体,来源于大流行前健康供体,结合 RBD-ACE2 界面。
Nat Commun. 2021 Mar 11;12(1):1577. doi: 10.1038/s41467-021-21609-2.
6
Predicting Promiscuous T Cell Epitopes for Designing a Vaccine Against Streptococcus pyogenes.预测用于设计针对酿脓链球菌疫苗的高变 T 细胞表位。
Appl Biochem Biotechnol. 2019 Jan;187(1):90-100. doi: 10.1007/s12010-018-2804-5. Epub 2018 Jun 11.
7
A Human Bi-specific Antibody against Zika Virus with High Therapeutic Potential.一种具有高治疗潜力的抗寨卡病毒人双特异性抗体。
Cell. 2017 Sep 21;171(1):229-241.e15. doi: 10.1016/j.cell.2017.09.002.
8
Modeling and docking of antibody structures with Rosetta.抗体结构的建模与对接 Rosetta 方法。
Nat Protoc. 2017 Feb;12(2):401-416. doi: 10.1038/nprot.2016.180. Epub 2017 Jan 26.
9
Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus.一种强效人源单克隆抗体对中东呼吸综合征冠状病毒的预防及暴露后疗效
Proc Natl Acad Sci U S A. 2015 Aug 18;112(33):10473-8. doi: 10.1073/pnas.1510199112. Epub 2015 Jul 27.
10
Protein engineering strategies for the development of viral vaccines and immunotherapeutics.蛋白质工程策略在病毒疫苗和免疫疗法研发中的应用。
FEBS Lett. 2014 Jan 21;588(2):298-307. doi: 10.1016/j.febslet.2013.10.014. Epub 2013 Oct 21.